PoliticalRepoPoliticalRepo

Bill · HR

H.R. 5160 (119th)

Stem Cell Therapeutic and Research Reauthorization Act of 2025

Original

openUnited States· United States Congress· EN

Introduced

4 September 2025

Last action

21 July 2026 · Introduced

Status

Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 464.

Sponsors

Rep. Smith, Christopher H. [R-NJ-4], Doris Matsui, Rep. Bilirakis, Gus M. [R-FL-12], Chellie Pingree, Rep. Tenney, Claudia [R-NY-24], Kweisi Mfume, Rep. Fischbach, Michelle [R-MN-7], Debbie Dingell, Rep. Gottheimer, Josh [D-NJ-5], Rep. Aderholt, Robert B. [R-AL-4], Rep. Malliotakis, Nicole [R-NY-11], Kathy Castor, Andrew Garbarino, Del. Norton, Eleanor Holmes [D-DC-At Large], Cliff Bentz, Nanette Barragán, Rep. Finstad, Brad [R-MN-1], Kelly Morrison, Rep. Lawler, Michael [R-NY-17], Rep. Vindman, Eugene Simon [D-VA-7], Rep. Fitzpatrick, Brian K. [R-PA-1], Sharice Davids

Subjects

Healthcare

Source updated

26 August 2026

Healthcare

Summary

Stem Cell Therapeutic and Research Reauthorization Act of 2025 This bill reauthorizes through FY2031 and revises programs that help patients receive transplants of bone marrow or umbilical cord blood from biologically unrelated donors. These programs are administered by the Health Resources and Services Administration (HRSA). The bill reauthorizes the C.W. Bill Young Cell Transplantation Program. This program supports transplantation of bone marrow and cord blood by increasing the quantities of donations, providing processes for matching and distributing donated materials to patients, and providing related information and research. Also, the bill reauthorizes and revises the National Cord Blood Inventory program, through which HRSA contracts with qualified cord blood banks to collect and maintain a supply of high-quality units for transplantation through the C.W. Bill Young Cell Transplantation Program. The bill amends the inventory program by (1) changing the inventory goal from 150,000 units to a sufficient supply as determined by HRSA, (2) requiring HRSA to manage the size and composition of the inventory to maximize clinical utility and efficiency, and (3) defining high quality cord blood unit to mean a unit meeting current industry standards and the requirements of the Food and Drug Administration.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 4 September 2025

    Introduced

    Introduced in House

    Source: IntroReferral

  2. 4 September 2025

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

  3. 4 September 2025

    Introduced

    Referred to the House Committee on Energy and Commerce.

    Source: IntroReferral

  4. 4 September 2025

    Introduced

    Introduced in House

    Source: IntroReferral

  5. 13 May 2026

    Committee

    Forwarded by Subcommittee to Full Committee by Voice Vote.

    Source: Committee

  6. 13 May 2026

    Committee

    Subcommittee Consideration and Mark-up Session Held

    Source: Committee

  7. 21 May 2026

    Vote

    Ordered to be Reported (Amended) by the Yeas and Nays: 48 - 0.

    Source: Committee

  8. 21 May 2026

    Committee

    Committee Consideration and Mark-up Session Held

    Source: Committee

  9. 2 July 2026

    Calendars

    Placed on the Union Calendar, Calendar No. 629.

    Source: Calendars

  10. 2 July 2026

    Reported

    Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-724.

    Source: Committee

  11. 2 July 2026

    Reported

    Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-724.

    Source: Committee

  12. 20 July 2026

    Passed

    Motion to reconsider laid on the table Agreed to without objection.

    Source: Floor

  13. 20 July 2026

    Passed

    On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H4642)

    Source: Floor

  14. 20 July 2026

    Passed

    Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H4642)

    Source: Floor

  15. 20 July 2026

    Floor

    DEBATE - The House proceeded with forty minutes of debate on H.R. 5160.

    Source: Floor

  16. 20 July 2026

    Floor

    Considered under suspension of the rules. (consideration: CR H4642-4643)

    Source: Floor

  17. 20 July 2026

    Floor

    Mr. Guthrie moved to suspend the rules and pass the bill, as amended.

    Source: Floor

  18. 21 July 2026

    Introduced

    Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 464.

    Source: Calendars

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

5 official files

Sponsors

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.